U.S. Slow To Ease Export Controls On High-Tech Items

WASHINGTON--One week after the Chernobyl nuclear plant exploded in April 1986, Soviet contacts called Carnegie Mellon University robot researcher William ("Red") Whittaker to ask for help in saving thousands of Soviet cleanup workers from radiation exposure. Whittaker's autonomous robots were already cleaning up the disabled Three Mile Island nuclear plant, and his technology was widely acknowledged as the world's best in replacing humans in hazardous environments. But a year later, after 5,00

Written byChristopher Anderson
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON--One week after the Chernobyl nuclear plant exploded in April 1986, Soviet contacts called Carnegie Mellon University robot researcher William ("Red") Whittaker to ask for help in saving thousands of Soviet cleanup workers from radiation exposure. Whittaker's autonomous robots were already cleaning up the disabled Three Mile Island nuclear plant, and his technology was widely acknowledged as the world's best in replacing humans in hazardous environments.

But a year later, after 5,000 Chernobyl workers had absorbed 125,000 rem of radiation, and Soviet robots had proved largely ineffective, Whittaker's technology had still not left the United States. The reason? Approval of the exchange took six months to pass through a labyrinth of U.S. export controls on high technology. By the time permission was finally granted, the Chernobyl cleanup was nearly over. No U.S. technology ever took part in the operation (The Scientist, Jan. 22, 1990, page 2).

The example, while extreme, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies